Early lesion detection with 18 F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer
Conclusion18F-DCFPyL PET/CT offers early detection of lesions in patients with BCR, even at PSA levels<0.5 ng/ml. These results appear to be comparable to those reported for68Ga-PSMA and18F-PSMA-1007, with potentially increased detection efficacy compared to68Ga-PSMA for patients with PSA<2.0.
Source: European Journal of Nuclear Medicine and Molecular Imaging - Category: Nuclear Medicine Source Type: research
More News: Brachytherapy | Cancer | Cancer & Oncology | CT Scan | External Beam Therapy | Netherlands Health | Nuclear Medicine | PET Scan | Prostate Cancer | Prostatectomy | Radiation Therapy | Study